Back
Open Access

The GLP1RA Semaglutide exerts significant cardioprotective properties against anthracycline+/-trastuzumab induced cardiotoxicity: biochemical evidences

Session: Cardio-oncology - diagnostic and therapeutic advances
Topic: Cardio-Oncology
Speaker: Doctor N. Maurea (Naples, IT)
Event: Heart Failure 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Nicola Maurea

National Cancer Institute G.Pascale Foundation IRCCS, Naples (Italy)
3 presentations
2 followers

6 more presentations in this session

GLP1-RA associated with PCSK9i as new therapy of anthracycline-induced cardiotoxicity under exposure to Ox-LDL: biochemical and preclinical evidences

Speaker: Doctor N. Maurea (Naples, IT)

Access
Abstract
Like
Thumbnail

Use of guideline directed medical therapy and clinical outcomes in cancer patients with de novo heart failure

Speaker: Doctor Y. Sener (Rotterdam, NL)

Access
Abstract
Like
Thumbnail

Detecting global cardiac involvement in breast cancer: the GAVS index

Speaker: Doctor C. Madaudo (Palermo, IT)

Access
Abstract
Like
Thumbnail

Echocardiographic indices of right ventricular function to predict cardiovascular outcomes in asian patients with cardiac amyloidosis

Speaker: Doctor N. Sari (Jakarta, ID)

Access
Abstract
Like
Thumbnail

Late cardiovascular toxicity in childhood cancer survivors from india: a cohort study.

Speaker: Professor R. Seth (Delhi, IN)

Access
Abstract
Like
Thumbnail

Access the full session

Cardio-oncology - diagnostic and therapeutic advances

Speakers: Doctor N. Maurea, Doctor N. Maurea, Doctor Y. Sener, Doctor C. Madaudo, Doctor N. Sari...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novartis Explore sponsored resources
logo Novo Nordisk Explore sponsored resources